Recent Updates — CHGA
Change Agents Corporation shareholders approved a proposal to increase the number of authorized shares of common stock from 100,000,000 to 125,000,000. The company also received shareholder approval for various equity issuances and plan amendments required to comply with Nasdaq Listing Rule 5635(d). Change Agents Corporation operates in the corporate compliance and governance services industry.
Change Agents Corporation appointed Eric Weisblum as an independent director on its board of directors, effective October 12, 2026. Mr. Weisblum will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. He is currently the CEO of Silo Pharma Inc., a biopharmaceutical company he founded in 2020, and brings decades of experience in investment banking, capital markets, and public company management. The appointment was announced via an 8-K filing on October 14, 2026. Change Agents Corporation operates as a financial services firm providing corporate finance advisory and investment banking services.
On September 30, 2026, Change Agents Corporation issued $336,000 in aggregate principal amount of Original Issue Discount Notes (Second Tranche September 2026 OID Notes) to accredited investors for gross proceeds of $300,000. The company utilized these net proceeds to repay $125,000 under June 2025 notes, redeem $125,000 of Series F Preferred Stock, and make a $37,125 installment payment on its July 2026 Business Loan. The OID Notes mature on April 30, 2027, accrue interest at 7% per annum (increasing to 15% upon default), and include negative covenants and most-favored-nation provisions. Additionally, the company issued pre-funded warrants for 100,000 shares of common stock as an inducement for investors. Separately, Chief Strategy Officer Luisa Ingargiola advanced $20,000 to facilitate a timely loan payment on September 28, 2026, which was repaid in October 2026. Change Agents Corporation operates in the business services industry, providing corporate compliance and governance solutions.
On August 14, 2026, Change Agents Corporation issued promissory notes to accredited investors with an aggregate principal amount of $616,000 (inclusive of a $66,000 original issuance discount) for gross proceeds of $550,000. The net proceeds will be used to repay existing debt obligations totaling $343,000, including amounts owed to Vanquish Funding Group Inc., notes issued in June 2025, and a July 2024 business loan, with the remainder allocated to working capital. The notes mature on May 14, 2027, accrue interest at 7% per annum (increasing to 15% upon default), and include negative covenants and a most-favored nations provision. Additionally, the company issued pre-funded warrants to purchase 1,000,000 shares of common stock as an inducement for investors, exercisable at $0.0001 per share subject to certain ownership limitations.